Secnidazole for treatment of bacterial vaginosis: a systematic review

• Egile Nagusiak: Mohamed A. Abd El Aziz (Egilea), Foruzan Sharifipour (Egilea), Parvin Abedi (Egilea), Shayesteh Jahanfar (Egilea), Helen Marie Judge (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2019-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Bacterial vaginosis (BV) is one of the common vaginal infections among childbearing women. The usual treatment for BV is metronidazole; hence 30% of women have recurrence within 60 to 90 days after treatment. There are some studies which assessed the effect of secnidazole on BV....